Intermountain Precision Genomics and Myriad Genetics Now Offer Solid Tumor Testing in All 50 States
NYS Department of Health Clinical Laboratory Evaluation Program certifies Intermountain Precision Genomics Laboratory.
Stay updated with breaking news from Solid Tumor Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NYS Department of Health Clinical Laboratory Evaluation Program certifies Intermountain Precision Genomics Laboratory.
/PRNewswire/ -- The "U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by End User, and Region - Analysis...
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by...
/PRNewswire/ -- The U.S. solid tumor testing market is projected to reach $18.28 billion in terms of revenue by 2032, at a CAGR of 6.19%, suggests the premium...